Progressive diseases: Interpretation of genetic data

Journal of Theoretical Medicine

Volumn 2, Issue 2, 1999, Pages 1-7

  Baum, L ^a   Baum, E ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Gene polymorphism Alzheimer modeling

Indexed keywords

APOLIPOPROTEIN E; DNA;

ACCURACY; ALLELE; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL PROTOCOL; CONTROLLED STUDY; DATA BASE; DISEASE COURSE; DISEASE MODEL; DNA DETERMINATION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC SCREENING; HUMAN; HUMAN CELL; PATIENT SELECTION; POPULATION RESEARCH; RISK ASSESSMENT; TIME; GENETIC RISK; POPULATION GENETICS; SAMPLE SIZE; SAMPLING;

EID: 0034425183     PISSN: 10273662     EISSN: None     Source Type: Journal    
DOI: 10.1080/17486709909490784     Document Type: Article

References (26)

1. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease
2. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease
3. Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease
4. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease
5. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: Relation to apolipoprotein E polymorphism
6. Apolipoprotein E genotype and its effect on duration and severity of early and late onset Alzheimer's disease
7. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease
8. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample
9. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians
10. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
11. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease
12. The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival
13. Apolipoprotein E epsilon 4 and the risk of dementia with stroke. A population-based investigation
14. APOE alleles in Alzheimer's disease and vascular dementia in a population aged 85+
15. Apolipoprotein E gene and sporadic frontal lobe dementia
16. The apolipoprotein E 4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease
17. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease
18. Presenilin-1 polymorphism in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia in Japanese population
19. No association or linkage between an intronic polymorphism of presenilin-1 and sporadic or late-onset familial Alzheimer disease
20. No association between the intronic presenilin-1 polymorphism and Alzheimer's disease in clinic and population-based samples
21. 2 dopamine receptor A1 allele in Alzheimer disease and aging
22. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease
23. Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson disease patients and in families
24. Frequency of a specific cytochrome P4502D6B (CYP2D6B) mutant allele in clinically differentiated groups of patients with Parkinson disease
25. Lipoprotein lipase mutations and Alzheimer's disease